MYO16
MYO16 (myosin XVI) is an unconventional, actin-based myosin that has been proposed to act as a regulatory subunit for protein phosphatase 1 and to influence neuronal morphogenesis. It is also known as MYR8, KIAA0865, Myo16b, NYAP3 and PPP1R107. Browse Assay Genie's current range of MYO16 research reagents below, or read on for the biology behind the target.
Myosins are actin-based motor molecules with ATPase activity, and unconventional myosins such as MYO16 serve in intracellular movements. Their highly divergent tails are presumed to bind membranous compartments, which would then be moved relative to actin filaments. UniProt annotation also indicates that MYO16 may be involved in targeting the catalytic subunit of protein phosphatase 1 during brain development, and that it activates PI3K while recruiting the WAVE1 complex to the close vicinity of PI3K, thereby regulating neuronal morphogenesis.
The MYO16 gene encodes an unconventional myosin protein that localises to the cytoplasm. In the C-terminal section it belongs to the NYAP family, which is reflected in the alias NYAP3. HGNC places it in three groups: ankyrin repeat domain containing proteins, protein phosphatase 1 regulatory subunits, and class XVI myosin heavy chains. The mouse and rat orthologs are both named Myo16, which allows comparative work in rodent systems.
The encoded protein has been proposed to act as a serine/threonine phosphatase-1 targeting or regulatory subunit, which explains the symbol PPP1R107. Studies in a rat cell line suggest that it may regulate cell cycle progression. A variant within the MYO16 gene may be associated with susceptibility to schizophrenia, and elevated expression has been observed in the frontal cortex of human schizophrenia patients.
MYO16 activates PI3K and recruits the WAVE1 complex nearby, making it relevant to studies of how neurons shape their morphology.
MYO16 is proposed to target or regulate the catalytic subunit of protein phosphatase 1 during brain development.
A MYO16 variant may be associated with schizophrenia susceptibility, and expression is elevated in the frontal cortex of patients.
Studies in a rat cell line suggest MYO16 may regulate cell cycle progression, prompting work on its non-motor roles.
MYO16 is an unconventional myosin, an actin-based motor with ATPase activity. UniProt notes it may help target the catalytic subunit of protein phosphatase 1 during brain development, activates PI3K and recruits the WAVE1 complex nearby, and so regulates neuronal morphogenesis.
The HGNC name is myosin XVI and UniProt lists unconventional myosin-XVI. Aliases include MYR8, KIAA0865, Myo16b, NYAP3 and PPP1R107. The NYAP3 name reflects its membership of the NYAP family in the C-terminal section.
NCBI Gene reports that a MYO16 variant may be associated with schizophrenia susceptibility, and that expression is elevated in the frontal cortex of patients. Mouse and rat both carry a Myo16 ortholog; check the datasheet of any product for its validated reactivity.
Other unconventional myosins and myosin heavy chain targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y6X6; product specifications from Assay Genie datasheets.